When cancer returned last year, it did so in a very different chapter of her life. This time, a rare stage IV sarcoma complicated her breast cancer. She now faced a difficult decision regarding ...
Please provide your email address to receive an email when new articles are posted on . Patients who received cryoablation as treatment for breast cancer had low recurrence rate after 16 months.
ProSense® is a minimally invasive cryosurgical tool that provides the option to destroy tumors by freezing them. The system ...
CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...
IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . XSense Cryoablation System with CryoProbes is cleared for general minimally invasive cryoablation. The system ...
The ProSense® Cryoablation System could be a game changer for women over 70 with early-stage, low-risk breast cancer. For decades, breast cancer treatment has often meant surgery, which can be an ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with early ...
The Gauteng MEC for Health & Wellness, Nomantu Nkomo-Ralehoko, announced on X (Twitter) that the Steve Biko Academic Hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results